NYSE · CIK 0001562528
FBRT Franklin BSP Realty Trust, Inc.
Insider trading from SEC Form 4. Last filing Jun 17, 2026. Close $6.19 on Oct 9, 2026, +1% from the 52-week low and -37% from the high.
In brief
Franklin BSP Realty Trust, Inc. (FBRT) has 21 SEC Form 4 filings on file from 10 insiders, the latest filed on Jun 17, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
4 open-market trades have been scored at FBRT. The newest: Buford H Ortale (director) bought $492k of stock on Sep 6, 2022, filed Jun 17, 2026, scored 43 (moderate). 2 insiders bought within 14 days of each other around Mar 3, 2026.
1 member of Congress has disclosed 2 trades in FBRT under the STOCK Act. 1 Form 144 notice of planned sales is on file, the latest filed Nov 21, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Franklin BSP Realty Trust, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Buford H Ortale director buy | $492k 39,597 shares | +671% | - | |
| 58Moderate | Brian Buffone President buy | $254k 27,000 shares | +12% | +9% from low-20% from high | |
| 46Moderate | Buford H Ortale director buy | $35k 4,000 shares | +8% | +2% from low-26% from high | |
| 15Weak | Peter J McDonough director sell | $15k 1,500 shares | -3% | +3% from low-19% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 21, 2025 | Peter J McDonough Director | 1,500 0.00% of outstanding | $15k | Nov 21, 2025 | none |
Congressional trades
2 trades in FBRT disclosed by members of Congress under the STOCK Act. All congressional trades.
- Lisa C. McClainHouse · R-MI · last Aug 13, 20251 bought
1 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Lisa C. McClain House · R-MI | Purchase | FBRT Franklin BSP Realty Trust, Inc. Common Stock | $1,001 to $15k | Jun 9, 2025 / Aug 13, 2025 65 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Sale | FBRT Franklin BSP Realty Trust, Inc. Common Stock | $1,001 to $15k | Jun 11, 2025 / Aug 13, 2025 63 days after the trade | Clerk |
Transactions
Every row filed, 30 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 6, 2022 | Buford H Ortale director | POpen-market purchase 7.50% Series E Cumulative Redeemable Preferred Stockindirect: By Trust | +10,000 | $20.00 | $200k | 15,900 | Jun 17, 2026 |
| Jun 15, 2026 | Buford H Ortale director | POpen-market purchase Common Stockindirect: By Trust | +25,900 | $8.44 | $219k | 28,900 | Jun 17, 2026 |
| Jun 15, 2026 | Buford H Ortale director | POpen-market purchase 7.50% Series E Cumulative Redeemable Preferred Stockindirect: By Trust | +3,697 | $19.75 | $73k | 19,597 | Jun 17, 2026 |
| Jun 8, 2026 | Elizabeth K. Tuppeny director | AGrant or award Common Stock | +12,835 | $0.00 | $0 | 62,742 | Jun 10, 2026 |
| Jun 8, 2026 | Patsy Joseph Augustine director | AGrant or award Common Stock | +12,835 | $0.00 | $0 | 49,062 | Jun 10, 2026 |
| Jun 8, 2026 | Buford H Ortale director | AGrant or award Common Stock | +12,835 | $0.00 | $0 | 64,686 | Jun 10, 2026 |
| Jun 8, 2026 | Peter J McDonough director | AGrant or award Common Stock | +12,835 | $0.00 | $0 | 58,761 | Jun 10, 2026 |
| Jun 8, 2026 | Joe Dumars director | AGrant or award Common Stock | +12,835 | $0.00 | $0 | 39,442 | Jun 10, 2026 |
| Mar 3, 2026 | Brian Buffone President | POpen-market purchase Common Stock | +27,000 | $9.41 | $254k | 243,081 | Mar 4, 2026 |
| Feb 17, 2026 | Buford H Ortale director | POpen-market purchase Common Stock | +2,000 | $8.88 | $18k | 49,851 | Feb 19, 2026 |
| Feb 18, 2026 | Buford H Ortale director | POpen-market purchase Common Stock | +2,000 | $8.77 | $18k | 51,851 | Feb 19, 2026 |
| Jan 27, 2026 | Jerome S. Baglien CFO and COO | AGrant or award Common Stock | +100,261 | $0.00 | $0 | 337,278 | Jan 28, 2026 |
| Jan 27, 2026 | Michael Comparato President | AGrant or award Common Stock | +66,841 | $0.00 | $0 | 538,455 | Jan 28, 2026 |
| Jan 27, 2026 | Richard J Byrne Chairman and CEO | AGrant or award Common Stock | +66,841 | $0.00 | $0 | 517,932 | Jan 28, 2026 |
| Jan 27, 2026 | Jerome S. Baglien CFO and COO | FTax withholding Common Stock | -27,264 | $10.17 | $277k | 310,014 | Jan 28, 2026 |
| Jan 27, 2026 | Richard J Byrne Chairman and CEO | FTax withholding Common Stock | -41,207 | $10.17 | $419k | 476,725 | Jan 28, 2026 |
| Jan 27, 2026 | Michael Comparato President | FTax withholding Common Stock | -28,584 | $10.17 | $291k | 509,871 | Jan 28, 2026 |
| Nov 21, 2025 | Peter J McDonough director | SOpen-market sale Common Stock | -1,500 | $10.00 | $15k | 45,926 | Nov 21, 2025 |
| May 28, 2025 | Patsy Joseph Augustine director | AGrant or award Common Stock | +10,036 | $0.00 | $0 | 36,227 | Jun 2, 2025 |
| May 28, 2025 | Joe Dumars director | AGrant or award Common Stock | +10,036 | $0.00 | $0 | 26,607 | Jun 2, 2025 |
| May 28, 2025 | Buford H Ortale director | AGrant or award Common Stock | +10,036 | $0.00 | $0 | 47,851 | Jun 2, 2025 |
| May 28, 2025 | Elizabeth K. Tuppeny director | AGrant or award Common Stock | +10,036 | $0.00 | $0 | 49,907 | Jun 2, 2025 |
| May 28, 2025 | Peter J McDonough director | AGrant or award Common Stock | +10,036 | $0.00 | $0 | 47,426 | Jun 2, 2025 |
| May 28, 2025 | Jamie Handwerker director | AGrant or award Common Stock | +10,036 | $0.00 | $0 | 47,444 | Jun 2, 2025 |
| Jan 27, 2025 | Jerome S. Baglien CFO and COO | AGrant or award Common Stock | +91,255 | $0.00 | $0 | 260,221 | Jan 29, 2025 |
| Jan 27, 2025 | Richard J Byrne Chairman and CEO | AGrant or award Common Stock | +106,969 | $0.00 | $0 | 490,066 | Jan 29, 2025 |
| Jan 27, 2025 | Michael Comparato President | AGrant or award Common Stock | +136,882 | $0.00 | $0 | 494,727 | Jan 29, 2025 |
| Jan 27, 2025 | Jerome S. Baglien CFO and COO | FTax withholding Common Stock | -23,204 | $12.44 | $289k | 237,017 | Jan 29, 2025 |
| Jan 27, 2025 | Richard J Byrne Chairman and CEO | FTax withholding Common Stock | -38,975 | $12.44 | $485k | 451,091 | Jan 29, 2025 |
| Jan 27, 2025 | Michael Comparato President | FTax withholding Common Stock | -23,113 | $12.44 | $288k | 471,614 | Jan 29, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Patsy Joseph Augustinedirector
- Jerome S. BaglienCFO and COO
- Brian BuffonePresident
- Richard J ByrneChairman and CEO
- Michael ComparatoPresident
- Joe Dumarsdirector
- Jamie Handwerkerdirector
- Peter J McDonoughdirector
- Buford H Ortaledirector
- Elizabeth K. Tuppenydirector
Questions about FBRT
Answered from the filings on this page, as of the latest one.
Are insiders buying FBRT?
No. In the last 90 days no insider at Franklin BSP Realty Trust, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade FBRT on the open market?
Buford H Ortale (director) bought $492k of FBRT on Sep 6, 2022 and filed the Form 4 on Jun 17, 2026. InsiderTell scored 43 (moderate).
How many insiders file Form 4 at Franklin BSP Realty Trust, Inc.?
10 people have filed a Form 4 at Franklin BSP Realty Trust, Inc., among them Patsy Joseph Augustine (director), Jerome S. Baglien (CFO and COO), Brian Buffone (President). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.